the Relationship of the Use of Eye Masks and Outcomes of Patients With Sepsis in Intensive Care Unit

NCT ID: NCT02304224

Last Updated: 2014-12-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-12-31

Study Completion Date

2016-02-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the study is to investigate the relationship of nocturnal use of eye masks and immune function, cerebral function and outcomes of patients with sepsis. Thus more efficient and comprehensive treatment could be provided for patients in the duration of admission in intensive care unit.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

1. Treatment for patients There are no significant difference in standardized treatment received by patients enrolled, as well as the light equipment bedside and the food supply time. Patients are randomly divided into Eye Masks Group and Control Group by computer tools. Patients in Eye Masks Group are applied with eye masks from 22: 00 to 6: 00 each night during the admission. Blood sample was collected from each patient immediately after enrollment (D0), 6:30 of Day 1 (D1), Day 1 (D2), Day 3 (D3), Day 4 (D4) after admission. Urine of 6:00-21:00 and 21:00-6:00 is also stored from D0 to D4.
2. Clinical data collection Data such as patient's age, gender, contact information, time from onset to admission, existence of septic shock, pathogen species, the site of infection, the existence of organ dysfunction, APACHE II score (Acute Physiology And Chronic Health Evaluation Scoring System) , SOFA (Sequential Organ Failure Assessment)score, the use of mechanical ventilation, vasoactive drugs, corticosteroids, sedative and analgesic medication, history of eye diseases and neurological diseases is collected from each patient who is included in the study. Follow-up data for daily daytime sleep time, existence of delirium, CPC score and GCS score on Day 7 and Day 28, length of stay and survival of 28 days after admission is also collected.
3. Sample collection and processing The blood samples collected in citrate anticoagulation tubes and the urine samples collected in specialized graduated cylinders are stored at room temperature. Staining and fixation were performed within 24 h after blood collection. The expression of Monocyte Human Leukocyte Antigen-DR is detected using flow cytometer. The concentration of 6-sulfatoxymelatonin in urine is detected by ELISA kit.
4. Cerebral Performance Category (CPC) CPC is a 5-category scale for measuring neurological status 2 weeks after cardiac arrest and CPC score 6 months after cardiac arrest. The 5 categories are: CPC 1, conscious and alert with good cerebral performance; CPC 2, conscious and alert with moderate cerebral performance; CPC 3, conscious with severe cerebral disability; CPC 4, comatose or in persistent vegetative state; and CPC 5, brain dead, circulation preserved.
5. Glasgow Coma Scale (GCS) The GCS was developed as a standardized method for healthcare practitioners to evaluate degree of altered consciousness in patients who had sustained head injuries. The GCS is comprised of three categories: eye opening, verbal response, and motor response. The score from each category is summed, to provide a total GCS score (range 3-15).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sepsis Sleep Deprivation Immune Suppression

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control

the patients with sepsis admitted in the intensive care unit aren't applied with eye masks at night

Group Type NO_INTERVENTION

No interventions assigned to this group

Eye masks

the patients with sepsis in the intensive care unit are applied with eye masks at night in the duration of admission

Group Type EXPERIMENTAL

eye masks

Intervention Type OTHER

eye masks from 21:00 to 6:00 each night during admission

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

eye masks

eye masks from 21:00 to 6:00 each night during admission

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Transferred into ICU before 21:00 the same day;
2. Consistent with the diagnosis of sepsis;
3. Written informed consent was obtained from patients or their family members.

Exclusion Criteria

1. Age \< 18 years;
2. With sleep disorders; mental illness; cancer; autoimmune diseases; dysfunction of liver or kidney;
3. History of using of immune-related drugs; melatonin receptor agonist or antagonist; sleep-aid or mental- related drugs;
4. History of accepting radiotherapy or chemotherapy;
5. Doing shift work before admission.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Shanghai 10th People's Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Chen Yuanzhuo

M.D.

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Yuanzhuo Chen, M.D.

Role: STUDY_CHAIR

Shanghai 10th People's Hospital

Wenjie Li, M.D.

Role: PRINCIPAL_INVESTIGATOR

Shanghai 10th People's Hospital

Huiqi Wang, M.D.

Role: PRINCIPAL_INVESTIGATOR

Shanghai 10th People's Hospital

Chengjin Gao, M.D.

Role: STUDY_DIRECTOR

Shanghai 10th People's Hospital

Hu Peng, M.D.

Role: STUDY_DIRECTOR

Shanghai 10th People's Hospital

Yugang Zhuang, M.D.

Role: PRINCIPAL_INVESTIGATOR

Shanghai 10th People's Hospital

Xiangyu Zhang, M.D.

Role: STUDY_DIRECTOR

Shanghai 10th People's Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Shanghai Tenth Hospital

Shanghai, , China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Yuanzhuo Chen, M.D.

Role: CONTACT

+821666304586

Wenjie Li, M.D.

Role: CONTACT

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

040114002

Identifier Type: -

Identifier Source: org_study_id